Cargando…
Low numbers of blood and salivary natural killer cells are associated with a better response to belimumab in primary Sjögren’s syndrome: results of the BELISS study
INTRODUCTION: In this study, we sought to address changes in blood lymphocyte subpopulations and labial salivary gland (LSG) inflammation after belimumab treatment in patients with primary Sjögren’s syndrome (pSS) and to identify predictors of response to treatment. METHODS: Sequential blood lymphoc...
Autores principales: | Seror, Raphaèle, Nocturne, Gaétane, Lazure, Thierry, Hendel-Chavez, Houria, Desmoulins, Frédéric, Belkhir, Rakiba, Ravaud, Philippe, Benbijja, Mohcine, Poirier-Colame, Vichnou, Taoufik, Yacine, Mariette, Xavier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4559969/ https://www.ncbi.nlm.nih.gov/pubmed/26336930 http://dx.doi.org/10.1186/s13075-015-0750-y |
Ejemplares similares
-
Large granular lymphocyte expansions in primary Sjögren’s syndrome: characteristics and outcomes
por: Baber, Alistair, et al.
Publicado: (2019) -
Characteristics of Sjögren’s syndrome associated with rheumatoid arthritis
por: Hassold, Nolan, et al.
Publicado: (2022) -
Comparison between primary Sjögren’s disease patients with high or low level of dryness
por: Kachaner, Alexandra, et al.
Publicado: (2023) -
Impact of patient ancestry on heterogeneity of Sjögren’s disease
por: Beydon, Maxime, et al.
Publicado: (2023) -
Efficacy of daratumumab in refractory primary Sjögren disease
por: Nocturne, Gaetane, et al.
Publicado: (2023)